Search research articles
Contact Us
Filters
Showing results (631-640 of 674) with videos related to
Page
of 68
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L Telli, Kirsten M Timms, Julia Reid, et al.
Cell Reports
|
May 3, 2018
CSF1R<sup>+</sup> Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B Candido, Jennifer P Morton, Peter Bailey, et al.
Communications Medicine
|
January 13, 2026
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised <sup>13</sup>C-MRI and mass spectrometry imaging
Ines Horvat-Menih, Ruth Casey, James Denholm, et al.
Cancer Research
|
May 19, 2005
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
Stephen R Wedge, Jane Kendrew, Laurent F Hennequin, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo
Sarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Cancer Cell
|
September 19, 2019
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Rene Jackstadt, Sander R van Hooff, Joshua D Leach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Sara M Tolaney, Hao Guo, Sonia Pernas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
Journal of the National Cancer Institute
|
June 30, 2014
Therapeutic targeting of integrin αvβ6 in breast cancer
Kate M Moore, Gareth J Thomas, Stephen W Duffy, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 674) with videos related to
Sort By:
Page
of 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L Telli, Kirsten M Timms, Julia Reid, et al.
Cell Reports
|
May 3, 2018
CSF1R<sup>+</sup> Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B Candido, Jennifer P Morton, Peter Bailey, et al.
Communications Medicine
|
January 13, 2026
Probing intratumoral metabolic compartmentalisation in a patient with fumarate hydratase-deficient renal cancer using clinical hyperpolarised <sup>13</sup>C-MRI and mass spectrometry imaging
Ines Horvat-Menih, Ruth Casey, James Denholm, et al.
Cancer Research
|
May 19, 2005
AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
Stephen R Wedge, Jane Kendrew, Laurent F Hennequin, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo
Sarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Cancer Cell
|
September 19, 2019
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
Rene Jackstadt, Sander R van Hooff, Joshua D Leach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Sara M Tolaney, Hao Guo, Sonia Pernas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
Journal of the National Cancer Institute
|
June 30, 2014
Therapeutic targeting of integrin αvβ6 in breast cancer
Kate M Moore, Gareth J Thomas, Stephen W Duffy, et al.
Page
of 68